Navigation Links
Cepheid Reports 2013 First Quarter Results
Date:4/18/2013

Thursday, April 18, 2013, to discuss the results.  To access the live webcast, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.  By automating highly complex and time-consuming manual procedures, the Company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases.  Through its strong molecular biology capabilities, the Company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

Use of Non-GAAP MeasuresThe Company has supplemented its reported GAAP financial information with non-GAAP measures that do not include employee stock-based compensation expense, amortization of purchased intangible assets and a tax benefit related to an intercompany intellectual property transaction.  The presentation of this additional information is not meant to be considered in isolation or as a substitute for results prepared in accordance with U.S. GAAP.
The Company's management uses the non-GAAP information internally to evaluate its ongoing business, continuing operational performance and cash requirements, and believes these non-GAAP measures are useful to investors as they provide a ba
'/>"/>

SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
2. Cepheid Announces Board of Directors Changes
3. Cepheid Reports 2012 Second Quarter Results
4. Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
5. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
6. Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year
7. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
8. Cepheid to Webcast Upcoming Financial Presentations
9. Cepheid Reports Fourth Quarter and Full Year 2011 Results
10. Cepheid Welcomes Senior Vice President of Human Resources
11. Global Nano-Materials Market 2002-2016: Nano-Materials Industry, Production Volumes, Revenues and End User Market Demand - MarketResearchReports.Biz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2014)... , July 17, 2014  Vanda Pharmaceuticals Inc. ... focused on the development and commercialization of products for ... it will release results for the second quarter of ... opens. The Company will host a ... 7, 2014, during which Vanda management will discuss the ...
(Date:7/17/2014)...  Prana Biotechnology (NASDAQ: PRAN ; ASX: ... development program for Alzheimer,s disease. Professor ... Mental Health, The University of Melbourne, will today include ... in his presentation at the Alzheimer,s Association International Conference ... The presentation is entitled: "How to change and ...
(Date:7/17/2014)... all know, some optical devices can only work with ... polarizer is necessary to shift the polarization direction of ... half-wave plate, which constructed out of a birefringent material ... half-wave plate depends on the thickness of the crystal, ... a half-wave plate is difficulty to integrate on circuits. ...
(Date:7/17/2014)... , July 17, 2014  Exelixis, Inc. (Nasdaq: ... company. EXEL developed two cancer treatments cabozantinib (Cabo, Cometriq) ... active component. The company has a partnership with Roche ... to earn approval in the treatment of melanoma by ... week. Cabo is marketed and distributed in the U.S. ...
Breaking Biology Technology:Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc. 2
... Inc. (TSX:SDI), a company developing products for the ... International Symposium on Intensive Care and Emergency Medicine ... feature a key scientific symposium entitled, "The Role ... thought leaders in the field of sepsis. Presentations ...
... - Up to $50 Million Potential Milestones plus Double ... Host Conference Call at 11:00 a.m. ET Today - ... Amex: NBY ), a mid-stage biopharmaceutical company ... of a wide range of infections without causing resistance, ...
... 23, 2009 Reston, Va. The American Institute ... for Composites (ASC) congratulate the winners of the inaugural ... Distinguished Professor of Mechanical and Aerospace Engineering at the ... A. Armstrong Distinguished Professor of Aeronautical and Astronautical Engineering ...
Cached Biology Technology:Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 3NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 4NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 5NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 6Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes Jr. Award 2
(Date:7/21/2014)... and think, "Of course! Why didn,t I think of ... own invention, sparking ideas and building possibilities. This type ... Station Program Science Office,s new 15-book Researcher,s Guide Series. ... in orbit, their mental wheels may begin to speed ... propose new research and potentially make discoveries that they ...
(Date:7/21/2014)... Lgar,s team at the INRS nergie Matriaux Tlcommunications ... a spatial and temporal resolution greatly exceeding that ... a femtosecond laser source to shoot a molecular ... vinylidene. An article presenting the advancement was recently ... . , "The approach we developed combines ...
(Date:7/21/2014)... -- Why does the word "dog" have meaning? If ... friend understand you? , Kansas State University philosopher Elliott ... his latest research, which focuses on long-standing philosophical questions ... two other philosophers and a mathematician are collaborating to ... acquires meaning. , "If I order a cappuccino at ...
Breaking Biology News(10 mins):International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4Philosopher uses game theory to understand how words, actions acquire meaning 2
... [Brown University] A computerized epidemiological model of the spread ... California in 2005 successfully predicted where 81.6 percent of human ... where the risk of infection turned out to be 39 ... research. The DYCAST software used in those predictions is now ...
... cells is a well-oiled machine with tiny protein motors hauling ... molecular motors are responsible for a variety of critical transport ... can put themselves into "energy save mode" to conserve cellular ... the cell, and when. A new study ...
... may not sound very glamorous, a new method of ... news for both confined animal operations and environmental groups, ... The method uses gas-permeable membrane technology that tests have ... in liquid manure in 20 days. The removed ammonium ...
Cached Biology News:Software predicted risk in California West Nile virus epidemic 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 3New technology could capture ammonia from liquid manure 2New technology could capture ammonia from liquid manure 3
GOAT ANTI FRK...
... Spots and complementary RNA Spikes for the ... for glass array printing and for protocol ... cDNA labeling, hybridization stringency and background. Normalize ... Spots and Oligo Spots, and complementary RNA ...
MOUSE ANTI S. MUTANS PEPTIDOGLYCAN...
For the quantitative determination of canine Interleukin 10,(IL-10) concentrations in cell culture supernates, canine serum,and plasma....
Biology Products: